Last reviewed · How we verify

NCT05741281

The Effect of Physical Exercises Program on Social Functioning, Alexithymia and Sense of Coherence Among Patients With Bipolar Disorders

Completed NA Last updated 23 February 2023
What this trial tests

NA trial testing Physical exercises program in Social Functioning, Alexithymia and Sense of Coherence , Bipolar Disorders in 40 participants. Completed in 5 February 2023.

Timeline
5 February 2022
Primary endpoint
5 December 2022
5 February 2023

Quick facts

Lead sponsorAlexandria University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment40
Start date5 February 2022
Primary completion5 December 2022
Estimated completion5 February 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

Eligibility, any sex, with Social Functioning, Alexithymia and Sense of Coherence , Bipolar Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to: Investigate the effect of applying physical exercises program on social functioning, alexithymia and sense of coherence among patients with bipolar disorders Research Hypotheses * Clients who participated in physical exercises program will exhibit better social functioning and sense of coherence than the control group. * Clients who participated in physical exercises program will exhibit less alexithymia than the control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05741281.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing